Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Outset Medical, Inc. - Common Stock (NQ:OM)

12.63 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Outset Medical, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Earnings Preview For Outset Medical
Outset Medical (NASDAQ:OM) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that Outset... 
Via Benzinga
Outset Medical to Present at SVB Leerink Global Healthcare Conference
From Outset Medical, Inc.
Via Business Wire
Outset Medical to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 16, 2022
From Outset Medical, Inc.
Via Business Wire
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Outset Medical's Tablo Hemodialysis System Cartridge Receives FDA Approval For Manufacturing In North America
The FDA has granted 510(k) clearance for Outset Medical Inc's (NASDAQ: OM) new sterilization method of the cartridge utilized in its Tablo Hemodialysis... 
Via Benzinga
Tablo® Hemodialysis System Cartridge Receives FDA 510(k) Clearance Enabling Production in North America
From Outset Medical, Inc.
Via Business Wire
Outset Medical Named to Fast Company’s First-Ever List of the Next Big Things in Tech
From Outset Medical, Inc.
Via Business Wire
Outset Medical Launches Inaugural ESG Report
From Outset Medical, Inc.
Via Business Wire
Outset Medical Inc (OM) Q3 2021 Earnings Call Transcript
OM earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Outset Medical Reports Third Quarter 2021 Financial Results
From Outset Medical, Inc.
Via Business Wire
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
Via Benzinga
Topics Retirement
Outset Medical to Present at Stifel 2021 Virtual Health Care Conference
From Outset Medical, Inc.
Via Business Wire
Outset Medical’s Tablo® Hemodialysis System Receives Landmark TPNIES Approval From CMS
From Outset Medical, Inc.
Via Business Wire
Outset Medical to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021
From Outset Medical, Inc.
Via Business Wire
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Outset Medical's Return On Capital Employed Insights
Outset Medical (NASDAQ:OM) brought in sales totaling $25.22 million during Q2 according to data provided by Benzinga Pro.However, earnings decreased 0.78%, resulting in a loss of... 
Via Benzinga
1 Beaten-Down Healthcare Stock to Put on Your Radar
This innovative company is well off its highs and could be worth a look. 
Via The Motley Fool
2 Beaten Down Stocks With 10X Potential
While there's no way to accurately predict the future, these stocks have a chance to produce tremendous returns if things go well. 
Via The Motley Fool
Outset Medical to Present at Upcoming September Investor Conferences
From Outset Medical, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2021
Upgrades According to Oppenheimer, the prior rating for The Wendy's Co (NASDAQ: 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday morning, 67 companies achieved new lows for the year. Areas of Significance: Grifols (NASDAQ:GRFS) was the largest firm by market cap to set a new 52-... 
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Outset Medical Reports Second Quarter 2021 Financial Results
From Outset Medical, Inc.
Via Business Wire
Outset Medical Names Nabeel Ahmed as Chief Financial Officer
From Outset Medical, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
Monday morning, 34 companies reached new 52-week lows. Things to Consider: Las Vegas Sands (NYSE:LVS) was the largest, in terms of market cap, to set a new 52-week... 
Via Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.